Funds and ETFs Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Market Closed - Nasdaq Copenhagen 15:59:34 08/05/2024 BST 5-day change 1st Jan Change
418.4 DKK +1.01% Intraday chart for Novonesis A/S +7.47% +12.75%

ETFs positioned on Novonesis A/S

Name Weight AuM 1st Jan change Investor Rating
1.80% 0 M€ +16.95%
0.50% 0 M€ +7.69% -
0.20% 88 M€ +10.37% -
0.14% 6 M€ -.--% -
0.11% 4 M€ -.--% -
0.11% 6 M€ -.--%
0.10% 0 M€ +8.19%
0.10% 3,859 M€ +18.82% -
0.10% 469 M€ -2.05% -
0.07% 0 M€ +3.57%
0.05% 23 M€ -.--% -
0.05% 786 M€ -.--%
0.05% 206 M€ -.--%
0.05% 10 M€ -3.35% -
0.05% 0 M€ +8.06%
0.05% 276 M€ +11.40% -
0.05% 0 M€ -.--% -
0.05% 0 M€ +8.31% -
0.05% 0 M€ +11.72%
0.04% 284 M€ -.--%
0.03% 0 M€ 0.00% -
0.03% 0 M€ +18.92%
0.02% 205 M€ -.--%
0.02% 0 M€ +7.95% -
0.02% 7 M€ +0.11% -
0.02% 607 M€ +0.05% -
0.02% 1,166 M€ +0.26% -
0.01% 0 M€ +8.70% -
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
418.4 DKK
Average target price
437.4 DKK
Spread / Average Target
+4.55%
Consensus
  1. Stock Market
  2. Equities
  3. NSIS B Stock
  4. Funds and ETFs Novonesis A/S